Kutscher EJ, Joshi SM, Patel AD, Hafeez B, Grinspan ZM.
2017.
Barriers to Genetic Testing for Pediatric Medicaid Beneficiaries With Epilepsy.. Pediatr Neurol. 73:28-35.
Ghomrawi HMK, Mancuso CA, Dunning A, Valle AGonzalez D, Alexiades M, Cornell C, Sculco T, Bostrom M, Mayman D, Marx RG et al..
2017.
Do Surgeon Expectations Predict Clinically Important Improvements in WOMAC Scores After THA and TKA? Clin Orthop Relat Res. 475(9):2150-2158.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..
2017.
Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..
2017.
Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berry K, Pesko MF, Hesdorffer DC, Shellhaas RA, Seirup JK, Grinspan ZM.
2017.
An evaluation of national birth certificate data for neonatal seizure epidemiology.. Epilepsia. 58(3):446-455.
Lohman MC, Cotton BP, Zagaria AB, Bao Y, Greenberg RL, Fortuna KL, Bruce ML.
2017.
Hospitalization Risk and Potentially Inappropriate Medications among Medicare Home Health Nursing Patients.. J Gen Intern Med. 32(12):1301-1308.
Demarest ST, Shellhaas RA, Gaillard WD, Keator C, Nickels KC, Hussain SA, Loddenkemper T, Patel AD, Saneto RP, Wirrell E et al..
2017.
The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.. Epilepsia. 58(12):2098-2103.
Demarest ST, Shellhaas RA, Gaillard WD, Keator C, Nickels KC, Hussain SA, Loddenkemper T, Patel AD, Saneto RP, Wirrell E et al..
2017.
The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.. Epilepsia. 58(12):2098-2103.
Keros S, Buraniqi E, Alex B, Antonetty A, Fialho H, Hafeez B, Jackson MC, Jawahar R, Kjelleren S, Stewart E et al..
2017.
Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals.. J Child Neurol. 32(7):638-646.
Shellhaas RA, Berg AT, Grinspan ZM, Wusthoff CJ, Millichap JJ, Loddenkemper T, Coryell J, Saneto RP, Chu CJ, Joshi SM et al..
2017.
Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus.. Pediatr Neurol. 75:73-79.
Shellhaas RA, Berg AT, Grinspan ZM, Wusthoff CJ, Millichap JJ, Loddenkemper T, Coryell J, Saneto RP, Chu CJ, Joshi SM et al..
2017.
Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus.. Pediatr Neurol. 75:73-79.
Gunter KE, Nocon RS, Gao Y, Casalino LP, Chin MH.
2017.
Medical Home Characteristics and Quality of Diabetes Care in Safety Net Clinics.. J Community Health. 42(2):303-311.
Gunter KE, Nocon RS, Gao Y, Casalino LP, Chin MH.
2017.
Medical Home Characteristics and Quality of Diabetes Care in Safety Net Clinics.. J Community Health. 42(2):303-311.